{"title":"抗磷脂综合征新分类标准- 2023","authors":"Jacek Musiał","doi":"10.5603/jtm.97795","DOIUrl":null,"url":null,"abstract":"Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the clinical presence of thrombotic episodes, and — in women — obstetric complications with the laboratory presence of antiphospholipid antibodies in blood. The main objective of this report is to present in detail the new American College of Rheumatology (ACR)/Alliance of Associations for Rheumatology (EULAR) APS classification criteria. According to EULAR methodology they include entry criterion indispensable to initiate classification process and contain 8 clinical and laboratory domains allowing to classify patient as having APS with 99% specificity.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"46 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New classification criteria for antiphospholipid syndrome — 2023\",\"authors\":\"Jacek Musiał\",\"doi\":\"10.5603/jtm.97795\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the clinical presence of thrombotic episodes, and — in women — obstetric complications with the laboratory presence of antiphospholipid antibodies in blood. The main objective of this report is to present in detail the new American College of Rheumatology (ACR)/Alliance of Associations for Rheumatology (EULAR) APS classification criteria. According to EULAR methodology they include entry criterion indispensable to initiate classification process and contain 8 clinical and laboratory domains allowing to classify patient as having APS with 99% specificity.\",\"PeriodicalId\":52961,\"journal\":{\"name\":\"Global Journal of Transfusion Medicine\",\"volume\":\"46 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global Journal of Transfusion Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/jtm.97795\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Journal of Transfusion Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/jtm.97795","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
New classification criteria for antiphospholipid syndrome — 2023
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the clinical presence of thrombotic episodes, and — in women — obstetric complications with the laboratory presence of antiphospholipid antibodies in blood. The main objective of this report is to present in detail the new American College of Rheumatology (ACR)/Alliance of Associations for Rheumatology (EULAR) APS classification criteria. According to EULAR methodology they include entry criterion indispensable to initiate classification process and contain 8 clinical and laboratory domains allowing to classify patient as having APS with 99% specificity.